These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


409 related items for PubMed ID: 9050993

  • 1. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC, Doniger J, Stöppler H, Sadaie MR, Rosenthal LJ.
    Oncogene; 1997 Feb 27; 14(8):937-43. PubMed ID: 9050993
    [Abstract] [Full Text] [Related]

  • 2. Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.
    Araujo JC, Doniger J, Kashanchi F, Hermonat PL, Thompson J, Rosenthal LJ.
    J Virol; 1995 Aug 27; 69(8):4933-40. PubMed ID: 7609062
    [Abstract] [Full Text] [Related]

  • 3. BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1.
    O'Brien V, Campo MS.
    Oncogene; 1998 Jul 23; 17(3):293-301. PubMed ID: 9690511
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product.
    Hermonat PL.
    Cancer Res; 1991 Jul 01; 51(13):3373-7. PubMed ID: 1647267
    [Abstract] [Full Text] [Related]

  • 5. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53.
    Kashanchi F, Araujo J, Doniger J, Muralidhar S, Hoch R, Khleif S, Mendelson E, Thompson J, Azumi N, Brady JN, Luppi M, Torelli G, Rosenthal LJ.
    Oncogene; 1997 Jan 23; 14(3):359-67. PubMed ID: 9018122
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P, Li W, Lorenzi MV, Miki T, Zakut R, Givol D, Pierce JH.
    Oncogene; 1996 Feb 15; 12(4):775-84. PubMed ID: 8632899
    [Abstract] [Full Text] [Related]

  • 7. The E5 gene of bovine papillomavirus type 1 is sufficient for complete oncogenic transformation of mouse fibroblasts.
    Bergman P, Ustav M, Sedman J, Moreno-Lopéz J, Vennström B, Pettersson U.
    Oncogene; 1988 May 15; 2(5):453-9. PubMed ID: 2836779
    [Abstract] [Full Text] [Related]

  • 8. Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation.
    Haugen TH, Lace MJ, Ishiji T, Sameshima A, Anson JR, Turek LP.
    Virology; 2009 Jun 20; 389(1-2):82-90. PubMed ID: 19410271
    [Abstract] [Full Text] [Related]

  • 9. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A, Bruder JT, Heidaran MA, App H, Rapp UR, Aaronson SA.
    Oncogene; 1993 Sep 20; 8(9):2443-8. PubMed ID: 8361757
    [Abstract] [Full Text] [Related]

  • 10. Inhibition/stimulation of bovine papillomavirus by adeno-associated virus is time as well as multiplicity dependent.
    Hermonat PL, Meyers C, Parham GP, Santin AD.
    Virology; 1998 Aug 01; 247(2):240-50. PubMed ID: 9705917
    [Abstract] [Full Text] [Related]

  • 11. Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines.
    Ratnam S, Kent C.
    Arch Biochem Biophys; 1995 Nov 10; 323(2):313-22. PubMed ID: 7487093
    [Abstract] [Full Text] [Related]

  • 12. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS, Cohen JD, Ehrlich LS, Bouck NP.
    Exp Cell Res; 1993 Apr 10; 205(2):232-9. PubMed ID: 8482334
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.
    Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L, Campo MS.
    Oncogene; 2002 Jan 10; 21(2):248-59. PubMed ID: 11803468
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor.
    Pim D, Collins M, Banks L.
    Oncogene; 1992 Jan 10; 7(1):27-32. PubMed ID: 1311063
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
    Chen JJ, Hong Y, Androphy EJ.
    Virology; 1997 Sep 15; 236(1):30-6. PubMed ID: 9299614
    [Abstract] [Full Text] [Related]

  • 18. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C, Fernandez-Medarde A, Rojas JM, Font de Mora J, Esteban LM, Santos E.
    Oncogene; 1998 Feb 05; 16(5):613-24. PubMed ID: 9482107
    [Abstract] [Full Text] [Related]

  • 19. A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1.
    Thompson J, Choudhury S, Kashanchi F, Doniger J, Berneman Z, Frenkel N, Rosenthal LJ.
    Oncogene; 1994 Apr 05; 9(4):1167-75. PubMed ID: 8134119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.